David Chang
President and Chief Executive Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Allogene Therapeutics, Inc. (ALLO) | M.D., Ph.D. President and Chief Executive Officer | $724,000 | $4,482,208 |
| 2023 | Allogene Therapeutics, Inc. (ALLO) | M.D., Ph.D. President and Chief Executive Officer | $724,000 | $14,063,848 |
| 2022 | Allogene Therapeutics, Inc. (ALLO) | M.D., Ph.D. President and Chief Executive Officer | $724,000 | $14,797,837 |
| 2021 | Allogene Therapeutics, Inc. (ALLO) | M.D., Ph.D. President and Chief Executive Officer | $695,000 | $10,161,454 |
| 2020 | Allogene Therapeutics, Inc. (ALLO) | M.D., Ph.D. President and Chief Executive Officer | $675,000 | $7,815,041 |
| 2019 | Allogene Therapeutics, Inc. (ALLO) | M.D., Ph.D. President and Chief Executive Officer | $600,000 | $11,192,110 |
| 2018 | Allogene Therapeutics, Inc. (ALLO) | M.D., Ph.D. President and Chief Executive Officer | $362,413 | $12,848,537 |
Executive changes
Earnings-call appearances
-
Allogene Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-13
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q4 FY2025 Earnings Call2026-03-12
Allogene Therapeutics, Inc. (ALLO)
-
So-Young International Inc. Q4 FY2025 Earnings Call2025-12-31
So-Young International Inc. (SY)
-
Allogene Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-06
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-13
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-13
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q4 FY2024 Earnings Call2025-03-13
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q3 FY2024 Earnings Call2024-12-02
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-13
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-14
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-02
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-02
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-03
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q4 FY2022 Earnings Call2023-02-28
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-02
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-09
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-04
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q4 FY2021 Earnings Call2022-02-23
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-04
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-04
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-05
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q4 FY2020 Earnings Call2021-02-25
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-04
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-05
Allogene Therapeutics, Inc. (ALLO)
-
Allogene Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-06
Allogene Therapeutics, Inc. (ALLO)